- Report
- October 2021
Bahrain
From €1327EUR$1,450USD£1,128GBP
- Report
- October 2021
Malaysia
From €1327EUR$1,450USD£1,128GBP
- Report
- October 2021
Lithuania
From €1327EUR$1,450USD£1,128GBP
- Report
- October 2021
Lebanon
From €1327EUR$1,450USD£1,128GBP
- Report
- October 2021
Latvia
From €1327EUR$1,450USD£1,128GBP
- Report
- October 2021
Kuwait
From €1327EUR$1,450USD£1,128GBP
- Report
- October 2021
Kazakhstan
From €1327EUR$1,450USD£1,128GBP
- Report
- October 2021
Jordan
From €1327EUR$1,450USD£1,128GBP
- Report
- October 2021
Jamaica
From €1327EUR$1,450USD£1,128GBP
- Report
- October 2021
Israel
From €1327EUR$1,450USD£1,128GBP
- Report
- October 2021
Austria
From €1327EUR$1,450USD£1,128GBP
- Report
- June 2020
- 400 Pages
Canada
From €2243EUR$2,450USD£1,906GBP
The Transfusion Diagnostics market is a segment of the In Vitro Diagnostics (IVD) industry. It focuses on the development and production of diagnostic tests used to detect and monitor blood-borne diseases, such as HIV, hepatitis, and syphilis. These tests are used to ensure the safety of blood transfusions and to monitor the health of blood donors. Transfusion Diagnostics tests are used in hospitals, blood banks, and other healthcare settings.
The Transfusion Diagnostics market is driven by the increasing demand for safe and reliable blood transfusions, as well as the need for improved patient safety. Additionally, the development of new technologies, such as molecular diagnostics, has enabled the development of more accurate and sensitive tests.
Some companies in the Transfusion Diagnostics market include Abbott, Bio-Rad Laboratories, Becton Dickinson, Ortho Clinical Diagnostics, and Siemens Healthineers. Show Less Read more